PharmaCielo's Q2 Report: GAAP EPS at -C$0.015 and Revenue Reaches C$0.78M
Friday, 16 August 2024, 16:21
Financial Highlights from PharmaCielo
PharmaCielo (PCLOF) has disclosed its Q2 financial results, registering a GAAP EPS of -C$0.015 and total revenue of C$0.78M. This reflects a remarkable year-over-year growth of 387.5%, showcasing the ongoing expansion in its operational capabilities.
Key Metrics
- Revenue Increase: C$0.78M
- Year-over-Year Growth: 387.5%
- GAAP EPS: -C$0.015
As PharmaCielo navigates through the evolving landscape of the cannabis industry, these figures highlight its potential for further development and investment opportunities.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.